|Articles|September 17, 2020
Resuming Operations After Fungal Contamination Following COVID-19 Shutdown
Author(s)Bioquell
Despite exhausting all disinfection methods after resuming operations this year, this international biologics provider repeatedly failed Environmental Monitoring test standards, delaying $5M in product release. See how Bioquell’s Rapid Bio Decontamination Service provided a fast, effective solution.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Ivonescimab Breakthrough Designation Highlights Progress in BTC Treatment
4
Women in STEM: Building Sustainable Cost and Access Models for Advanced Therapies (Part 1)
5